Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Ra Medical Systems Inc is a medical devices business based in the US. Ra Medical Systems shares (RMED) are listed on the NYSE MKT and all prices are listed in US Dollars. Ra Medical Systems employs 67 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Long-term investors
Our top pick for
Beginners
Our top pick for
Active traders
| Latest market close | $1.05 |
|---|---|
| 52-week range | $0.94 - $9.82 |
| 50-day moving average | $1.85 |
| 200-day moving average | $3.20 |
| Wall St. target price | $12.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-6.66 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.05 from 2022-01-25
| 1 week (2022-01-16) | N/A |
|---|---|
| 1 month (2021-12-27) | -37.50% |
| 3 months (2021-10-27) | -65.12% |
| 6 months (2021-07-27) | -67.59% |
| 1 year (2021-01-27) | -85.00% |
|---|---|
| 2 years (2020-01-27) | -42.62% |
| 3 years (2019-01-25) | 8.17 |
| 5 years (2017-01-23) | N/A |
| Revenue TTM | $4.2 million |
|---|---|
| Gross profit TTM | $-1,077,000 |
| Return on assets TTM | -56.51% |
| Return on equity TTM | -114.97% |
| Profit margin | 0% |
| Book value | $3.06 |
| Market capitalisation | $7 million |
TTM: trailing 12 months
We're not expecting Ra Medical Systems to pay a dividend over the next 12 months.
Ra Medical Systems's shares were split on a 1:25 basis on 16 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ra Medical Systems shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Ra Medical Systems shares which in turn could have impacted Ra Medical Systems's share price.
Over the last 12 months, Ra Medical Systems's shares have ranged in value from as little as $0.94 up to $9.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Ra Medical Systems's is 1.392. This would suggest that Ra Medical Systems's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Ra Medical Systems, Inc. , a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light and is used as a tool in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Read our expert analysis on Vigorus and how the token will perform in the future.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut earns up to 10% APY, but you must have an iOS device.
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.